Literature DB >> 32951438

Awareness of and interest in oral pre-exposure prophylaxis (PrEP) for HIV prevention and interest in hypothetical forms of PrEP among people who inject drugs in rural West Virginia.

Kristin E Schneider1, Rebecca Hamilton White2, Allison O'Rourke3, Michael E Kilkenny4, Michelle Perdue4, Susan G Sherman2, Suzanne M Grieb5, Sean T Allen2.   

Abstract

Injection drug use-associated HIV outbreaks have occurred in rural communities throughout the United States, which often have limited HIV prevention services for people who inject drugs (PWID). Pre-exposure prophylaxis (PrEP) is one tool that may help fill gaps in HIV prevention programing in rural settings. Oral PrEP has been approved for use, and new PrEP formulations are under development. Research is needed to better understand interest in oral and possible forthcoming PrEP formulations among PWID. We used survey data from 407 PWID in rural West Virginia. We asked if participants had heard of, taken, and were interested in taking PrEP, and about interest in several hypothetical forms of PrEP (arm injections, abdomen injections, implants, intravenous infusions). We estimated the prevalence of interest in each formulation and assessed correlates using Chi-squared tests. A minority had heard of oral PrEP (32.6%), and few had used it (3.7%). Many were interested in using oral PrEP (58.3%). Half were interested in arm injections (55.7%). Common correlates of interest across PrEP formulations were sexual minority status, comfort talking to a doctor about sex, sex work, and sharing injection equipment. Oral and injectable PrEP have the potential to fill HIV prevention gaps for rural PWID.

Entities:  

Keywords:  HIV prevention; people who inject drugs; pre-exposure prophylaxis (PrEP); rural health

Mesh:

Substances:

Year:  2020        PMID: 32951438      PMCID: PMC7981279          DOI: 10.1080/09540121.2020.1822506

Source DB:  PubMed          Journal:  AIDS Care        ISSN: 0954-0121


  29 in total

1.  Syringe Service Programs for Persons Who Inject Drugs in Urban, Suburban, and Rural Areas - United States, 2013.

Authors:  Don C Des Jarlais; Ann Nugent; Alisa Solberg; Jonathan Feelemyer; Jonathan Mermin; Deborah Holtzman
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2015-12-11       Impact factor: 17.586

2.  Willingness to use HIV pre-exposure prophylaxis among opiate users.

Authors:  Michael Stein; Portia Thurmond; Genie Bailey
Journal:  AIDS Behav       Date:  2014-09

3.  A missing perspective: injectable pre-exposure prophylaxis for people who inject drugs.

Authors:  K B Biello; A Edeza; P Salhaney; D L Biancarelli; M J Mimiaga; M L Drainoni; E S Childs; A R Bazzi
Journal:  AIDS Care       Date:  2019-03-01

4.  Estimating the Number of People Who Inject Drugs in A Rural County in Appalachia.

Authors:  Sean T Allen; Allison O'Rourke; Rebecca Hamilton White; Kristin E Schneider; Michael Kilkenny; Susan G Sherman
Journal:  Am J Public Health       Date:  2019-01-24       Impact factor: 9.308

5.  Correlates of willingness to initiate pre-exposure prophylaxis and anticipation of practicing safer drug- and sex-related behaviors among high-risk drug users on methadone treatment.

Authors:  Roman Shrestha; Pramila Karki; Frederick L Altice; Tania B Huedo-Medina; Jaimie P Meyer; Lynn Madden; Michael Copenhaver
Journal:  Drug Alcohol Depend       Date:  2017-02-02       Impact factor: 4.492

6.  Preexposure Prophylaxis for the Prevention of HIV Infection: US Preventive Services Task Force Recommendation Statement.

Authors:  Douglas K Owens; Karina W Davidson; Alex H Krist; Michael J Barry; Michael Cabana; Aaron B Caughey; Susan J Curry; Chyke A Doubeni; John W Epling; Martha Kubik; C Seth Landefeld; Carol M Mangione; Lori Pbert; Michael Silverstein; Melissa A Simon; Chien-Wen Tseng; John B Wong
Journal:  JAMA       Date:  2019-06-11       Impact factor: 56.272

7.  Polysubstance use in rural West Virginia: Associations between latent classes of drug use, overdose, and take-home naloxone.

Authors:  Kristin E Schneider; Allison O'Rourke; Rebecca Hamilton White; Ju Nyeong Park; Raschelle J Musci; Michael E Kilkenny; Susan G Sherman; Sean T Allen
Journal:  Int J Drug Policy       Date:  2020-01-07

8.  Factors associated with methadone maintenance therapy discontinuation among people who inject drugs.

Authors:  Ada Lo; Thomas Kerr; Kanna Hayashi; M-J Milloy; Ekaterina Nosova; Yang Liu; Nadia Fairbairn
Journal:  J Subst Abuse Treat       Date:  2018-08-23

9.  Stigma at every turn: Health services experiences among people who inject drugs.

Authors:  Catherine E Paquette; Jennifer L Syvertsen; Robin A Pollini
Journal:  Int J Drug Policy       Date:  2018-04-30

10.  Qualitative investigation of barriers to accessing care by people who inject drugs in Saskatoon, Canada: perspectives of service providers.

Authors:  Katherine Lang; Jaycie Neil; Judith Wright; Colleen Anne Dell; Shawna Berenbaum; Anas El-Aneed
Journal:  Subst Abuse Treat Prev Policy       Date:  2013-10-01
View more
  5 in total

1.  Long-Acting Injectable Human Immunodeficiency Virus Pre-Exposure Prophylaxis Preferred Over Other Modalities Among People Who Inject Drugs: Findings from a Qualitative Study in California.

Authors:  Angela R Bazzi; Chad J Valasek; Samantha A Streuli; Carlos F Vera; Alicia Harvey-Vera; Morgan M Philbin; Katie B Biello; Alexis M Roth; Steffanie A Strathdee; Heather A Pines
Journal:  AIDS Patient Care STDS       Date:  2022-06-21       Impact factor: 5.944

2.  An Experimental Study of the Effects of Patient Race, Sexual Orientation, and Injection Drug Use on Providers' PrEP-Related Clinical Judgments.

Authors:  Sarah K Calabrese; David A Kalwicz; Djordje Modrakovic; Valerie A Earnshaw; E Jennifer Edelman; Samuel R Bunting; Ana María Del Río-González; Manya Magnus; Kenneth H Mayer; Nathan B Hansen; Trace S Kershaw; Joshua G Rosenberger; Douglas S Krakower; John F Dovidio
Journal:  AIDS Behav       Date:  2021-11-09

3.  Mapping Interests in Event-Driven and Long-Acting Pre-exposure Prophylaxis Formulations onto the HIV Risk Environment of Street-Based Female Sex Workers: A Latent Class Analysis.

Authors:  Joseph G Rosen; Ju Nyeong Park; Kristin E Schneider; Rebecca Hamilton White; S Wilson Beckham; Jennifer L Glick; Katherine H A Footer; Susan G Sherman
Journal:  AIDS Behav       Date:  2022-04-01

4.  Preference for using a variety of future HIV pre-exposure prophylaxis products among men who have sex with men in three US cities.

Authors:  Gordon Mansergh; Krishna Kiran Kota; Rob Stephenson; Sabina Hirshfield; Patrick Sullivan
Journal:  J Int AIDS Soc       Date:  2021-01       Impact factor: 6.707

5.  The HIV pre-exposure prophylaxis continuum of care among women who inject drugs: A systematic review.

Authors:  Danielle Guy; Jason Doran; Trenton M White; Lena van Selm; Teymur Noori; Jeffrey V Lazarus
Journal:  Front Psychiatry       Date:  2022-08-26       Impact factor: 5.435

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.